1-9 of 9
Makoto Sasaki
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

DNAM-1/Tigit/CD155/CD112 Axis Is a Novel Target of NK-Cell Therapy in Acute Myeloid Leukemia

Yuta Kaito, Emi Sugimoto, Fumi Nakamura, Yutaka Tsukune, Makoto Sasaki, Shunsuke Yui, Hiroki Yamaguchi, Susumu Goyama, Yasuhito Nannya, Kinuko Mitani, Hideto Tamura, Yoichi Imai
Journal: Blood
Blood (2022) 140 (Supplement 1): 4514–4516.
https://doi.org/10.1182/blood-2022-164435
Published: 2022
Journal Articles

Serum Soluble CD86, Still a Prognostic Factor in the Novel Agent Era in Multiple Myeloma Patients, Is Produced By Myeloma Cells with High CD86 Variant 3 Expression

Mariko Ishibashi, PhD, Ryosuke Kinoshita, MD, Koiti Inokuchi, MD PhD Prof., Hiroshi Handa, MD PhD, Makoto Sasaki, MD PhD, Norio Komatsu, MD PhD, Yoichi Imai, MD PhD, Norina Hiroike, MD PhD, Junji Tanaka, Sakae Tanosaki, MD PhD, Shigeki Ito, MD, PhD, Mika Sunakawa, MD, Toshio Asayama, MD, Yasuko Kuribayashi-hamada, MD, Rimpei Morita, MD PhD, Hideto Tamura, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4361.
https://doi.org/10.1182/blood-2019-124635
Published: 2019
Journal Articles

Successful MPB Therapy Followed By Bortezomib Maintenance for Non-Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma: Japanese Phase 2 Study - Broad-J Study

Michihide Tokuhira, MD, Naoki Takezako, MD PhD, Yoichi Imai, MD PhD, Tadao Ishida, MD, Tomonori Nakazato, MD PhD, Kinuko Mitani, MD, PhD, Tohru Ikuta, MDPhD, Morio Matsumoto, MD, Takayuki Ikezoe, MD, PhD, Jun Taguchi, MD PhD, Kensuke Usuki, MD PhD, Takeshi Shimomura, MD, Kenkou Chin, MD, Shunya Arai, MD PhD, Kazuma Ohyashiki, MD, Miho Nara, MD, Kenji Kishi, MD, Yoshiaki Kuroda, MD, Yuichi Nakamura, MD, Hisashi Wakita, MD PhD, Makoto Sasaki, MD PhD, Hirotoshi Kamata, MD, Yoshikazu Ichikawa, MD, Akihiko Yokoyama, MD, Kenshi Suzuki, Masahiro Kizaki, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5432.
https://doi.org/10.1182/blood.V130.Suppl_1.5432.5432
Published: 2017
Journal Articles

The New Immunoreceptor SLAMF3 Promotes Aggressive Biological and Clinical Characteristics in Multiple Myeloma

Mariko Ishibashi, PhD, Hideto Tamura, MD PhD, Toshio Asayama, MD, Yasuko Kuribayashi-hamada, MD, Asaka Onodera, MDPhD, Keiichi Moriya, MD PhD, Makoto Sasaki, MD PhD, Hiroshi Handa, MD PhDChief Division, Yoichi Imai, MDPhD, Norina Tanaka, MD, Junji Tanaka, MD PhD, Sakae Tanosaki, MDPhD, Shigeki Ito, MD PhD, Norio Komatsu, MD PhD, Koiti Inokuchi, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3055.
https://doi.org/10.1182/blood.V130.Suppl_1.3055.3055
Published: 2017
Journal Articles

Retrospective Analysis of Prognostic Factors for Waldenström Macroglobulinemia: A Multicenter Cooperative Study in Japan

Akio Saito, MD PhD, Atsushi Isoda, MD PhD, Akihiko Yokohama, MD PhD, Hiroshi Handa, MD PhD, Norifumi Tsukamoto, MD PhD, Yutaka Tsukune, Makoto Sasaki, MD PhD, Morio Matsumoto, MD, Morio Sawamura, MDPhD, Shigeki Ito, MD PhD, Kohtaro Toyama, MD PhD, Michiaki Koike, Kayoko Murayama, MD, Asaka Onodera, MDPhD, Keiichi Moriya, MD PhD, Hideto Tamura, MD PhD, Hirotaka Nakahashi, MD PhD, Sakae Tanosaki, Toru Sakura, Masamitsu Karasawa, MD PhD, Masanori Iwashina, Masaru Kojima, MD PhD, Naoya Nakamura, MD PhD, Hirokazu Murakami, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5028.
https://doi.org/10.1182/blood.V126.23.5028.5028
Published: 2015
Journal Articles

Clinical Utility of Slam Family Member CD229 in Identifying Tumor Cells and High-Risk Disease Markers, CD86 (B7-2) and CD126 (IL-6 receptor), Using Flow Cytometric Analysis in Multiple Myeloma

Akiko Yamada, MD, Hideto Tamura, MD PhD, Mariko Ishibashi, PhD, Koiti Inokuchi, MD PhD, Makoto Sasaki, MD PhD, Yuriko Yahata, MD, Norio Komatsu, MD PhD, Atsushi Isoda, MD PhD, Morio Matsumoto, Hiroshi Handa, MD PhD, Yoichi Imai, MD PhD, Junji Tanaka, MD PhD, Sakae Tanosaki, MD PhD, Shigeki Ito, MD, PhD, Yoji Ishida, MD, PhD, Michiaki Koike, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2063.
https://doi.org/10.1182/blood.V124.21.2063.2063
Published: 2014
Journal Articles

Interaction Between B7-H1 Molecules on Myeloma Cells and PD-1 Molecules on T Cells Induces Resistance to Antimyeloma Chemotherapy

Mariko Ishibashi, PhD, Hideto Tamura, MD PhD, Mika Sunakawa, Asaka Kondo-Onodera, MD PhD, Keiichi Moriya, MD PhD, Namiko Okuyama, MD, Yasuko Hamada, MD, Atsushi Isoda, MD PhD, Morio Matsumoto, MD, Makoto Sasaki, MD PhD, Norio Komatsu, MD PhD, Hiroshi Handa, MD PhD, Yoichi Imai, MD PhD, Junji Tanaka, MD PhD, Sakae Tanosaki, MD PhD, Shigeki Ito, MD, PhD, Yoji Ishida, MD, PhD, Michiaki Koike, MD PhD, Koji Tamada, MD PhD, Koiti Inokuchi, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2018.
https://doi.org/10.1182/blood.V124.21.2018.2018
Published: 2014
Journal Articles

Novel Prognostic Model Of Primary Mediastinal Large B-Cell Lymphoma (PMBL): A Multicenter Cooperative Retrospective Study In Japan

Tomohiro Aoki, M.D., Koji Izutsu, MD, PhD, Ritsuro Suzuki, MD, Chiaki Nakaseko, M.D., Ph.D., Hiroshi Arima, M.D., Kazuyuki Shimada, M.D., Ph.D., Makoto Sasaki, M.D., Ph.D., Jun Takizawa, M.D., Ph.D., Kinuko Mitani, M.D., Ph.D., Tadahiko Igarashi, M.D., Yoshinobu Maeda, M.D., Ph.D., Fumihiro Ishida, M.D., Nozomi Niitsu, M.D., Ph.D., Ken Ohmachi, M.D., Hirotaka Takasaki, M.D., Naoya Nakamura, M.D., Ph.D., Tomohiro Kinoshita, MD, PhD, Shigeo Nakamura, MD, PhD, Michinori Ogura, M.D., Ph.D.
Journal: Blood
Blood (2013) 122 (21): 638.
https://doi.org/10.1182/blood.V122.21.638.638
Published: 2013
Journal Articles

Severe pulmonary complications in Japanese patients after bortezomib treatment for refractory multiple myeloma

Clinical Trials & Observations Brief Report
Shigesaburo Miyakoshi, Masahiro Kami, Koichiro Yuji, Tomoko Matsumura, Masaaki Takatoku, Makoto Sasaki, Hiroto Narimatsu, Takeshi Fujii, Masateru Kawabata, Shuichi Taniguchi, Keiya Ozawa, Kazuo Oshimi
Journal: Blood
Blood (2006) 107 (9): 3492–3494.
https://doi.org/10.1182/blood-2005-11-4541
Published: 2006